The Immunogenicity of a Cell‐derived H7N1 Split Influenza Virion Vaccine in Mice
Solveig Hauge(University of Bergen), Rebecca Jane Cox(Haukeland University Hospital), F. R. Vogel(Sanofi (France)), Maria Zambon(Public Health England), Abdullah S. Madhun(Norwegian Institute of Marine Research), Karl A. Brokstad(Western Norway University of Applied Sciences), John Wood(Women's and Children's Hospital), Diane Major(National Institute for Biological Standards and Control), Lars R. Haaheim(University of Bergen)
Cited by 1
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
|Journal of Clinical Investigation|2008|349